Your browser doesn't support javascript.
loading
Safety and immunogenicity of a quadrivalent seasonal influenza vaccine adjuvanted with hydroxypropyl-ß-cyclodextrin: A phase 1 clinical trial.
Watanabe, Akane; Nishida, Sumiyuki; Burcu, Temizöz; Shibahara, Takayuki; Kusakabe, Takato; Kuroda, Etsushi; Ishii, Ken J; Kumanogoh, Atsushi.
Afiliação
  • Watanabe A; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Japan; Laboratory of Thermo-therapeutics for vascular dysfunction, Osaka University, Suita, Osaka, Japan.
  • Nishida S; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Japan. Electronic address: sumiyuki-n@imed3.med.osaka-u.ac.jp.
  • Burcu T; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan; Laboratory of Vaccine Science, Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan; Division of Vaccine Science, Department of Microbiology and
  • Shibahara T; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Japan; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan.
  • Kusakabe T; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan.
  • Kuroda E; Department of Immunology, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
  • Ishii KJ; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, Japan; Laboratory of Vaccine Science, Immunology Frontier Research Center, Osaka University, Suita, Osaka, Japan; Division of Vaccine Science, Department of Microbiology and
  • Kumanogoh A; Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Japan; Department of Immunopathology, WPI, Immunology Frontier Research Center (iFReC), Osaka University, Suita, Osaka, Japan; Integrated Frontier Research for Medical Science Division,
Vaccine ; 40(31): 4150-4159, 2022 07 29.
Article em En | MEDLINE | ID: mdl-35672178
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão